In vitro tests of T cell-mediated drug hypersensitivity

Expert Review of Clinical Immunology

Volumn 2, Issue 6, 2006, Pages 887-900

  Beeler, Andreas ^a   Pichler, Werner J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Activation markers; Cytotoxicity; Drug hypersensitivity; Flow cytometry; IFN ; IL; Immediate reactions; Predictive test; Proliferation assays; T cell mediated reactions

Indexed keywords

EID: 37749029560     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/1744666X.2.6.887     Document Type: Review

References (97)

1. Pichler WJ. Delayed drug hypersensitivity reactions. Ann. Intern. Med. 139(8), 683-693 (2003).
2. Einarson TR. Drug-related hospital admissions. Ann. Pharmacother. 27(7-8), 832-840 (1993). (Pubitemid 23225664)
3. Naisbitt DJ, Gordon SF, Pirmohamed M, Park BK. Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment. Drug. Saf. 23(6), 483-507 (2000). (Pubitemid 32001512)
4. Hunziker T, Bruppacher R, Kuenzi UP et al. Classification of ADRs: a proposal for harmonization and differentiation based on the experience of the Comprehensive Hospital Drug Monitoring Bern/St. Gallen, 1974-1993. Pharmacocpidemiol. Drug. Saf. 11(2), 159-163(2002). (Pubitemid 34464337)
5. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N. Engl J. Med. 331(19), 1272-1285 (1994). (Pubitemid 24333193)
6. Coombs R, Gell P. Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Clinical Aspects of Immunology (2nd Edition). Coombs R (Ed.). Oxford University Press, Oxford, UK, 575-596 (1968).
7. Barbaud A, Reichert-Penetrat S, Tréchot P. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br. J. Dermatol. 139, 49-58 (1998). (Pubitemid 28338063)
8. Torres MJ, Bianca M, Fernandez J et al. Diagnosis of immediate allergic reactions to β-lactam antibiotics. Allergy 58(10), 961-972 (2003). (Pubitemid 37260337)
9. Romano A, Bianca M, Torres MJ et al. Diagnosis of nonimmediate reactions to β-lactam antibiotics. Allergy 59(11), 1153-1160(2004). (Pubitemid 39389467)
10. Aberer W, Bircher A, Romano A et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 58(9), 854-863 (2003). (Pubitemid 37046682)
11. Ricci M, Del Prete G F, Maggi E et al. In vitro IgE production by human lymphocytes and its regulation. Monogr. Allergy 18, 61-68 (1983).
12. Sanchez-Sancho F, Perez-Inestrosa E, Suau R et al. Synthesis, characterization and immunochemical evaluation of cephalosporin antigenic determinants. J. Mol. Recognit. 16(3), 148-156 (2003). (Pubitemid 36815054)
13. Gomez MB, Torres MJ, Mayorga C et al. Immediate allergic reactions to β lactams: facts and controversies. Curr. Opin. Allergy Clin. Immunol. 4(4), 261-266 (2004). (Pubitemid 39006839)
14. Baldo BA, Harle DG. Drug allergenic determinants. Monogr. Allergy 28, 11-51 (1990).
15. Manfredi M, Severino M, Testi S et al. Detection of specific IgE to quinolones. J. Allergy Clin. Immunol. 113(1), 155-160 (2004). (Pubitemid 38096176)
16. Paris-Kohier A, Demoly P, Persi L et al. In vitro diagnosis of cypress pollen allergy by using cytofluorimetric analysis of basophils (Basotest). J. Allergy Clin. Immunol. 105(2 Pt 1), 339-345 (2000). (Pubitemid 30109049)
17. Sanz ML, Gamboa PM, Antepara I et al. Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate-type reactions to βlactam antibiotics. Clin. Exp. Allergy 32(2), 277-286 (2002). (Pubitemid 34429608)
18. Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 59(8), 809-820 (2004). (Pubitemid 39005820)
19. Gamboa PM, Sanz ML, Caballero MR et al. Use of CD63 expression as a marker of in vitro basophil activation and leukotriene determination in metamizol allergic patients. Allergy 58(4), 312-317 (2003). (Pubitemid 36566749)
20. Gamboa P, Sanz ML, Caballero MR et al. The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome. Clin. Exp. Allergy 34(9), 1448-1457 (2004). (Pubitemid 39233702)
21. Yawalkar N, Hari Y, Frutig K et al. T cells isolated from positive epicutaneous test reactions to amoxicillin and ceftriaxone are drug specific and cytotoxic. J. Invest. Dermatol 115(4), 647-652 (2000).
22. Naisbitt DJ. Drug hypersensitivity reactions in skin: understanding mechanisms and the development of diagnostic and predictive tests. Toxicology 194(3), 179-196 (2004). (Pubitemid 37542452)
23. Naisbitt DJ, Farrell J, Wong G et al. Characterization of drug-specific T cells in lamotrigine hypersensitivity. J. Allergy Clin. Immunol. 111(6), 1393-1403(2003). (Pubitemid 36683697)
24. Hari Y, Frutig-Schnyder K, Hurni M et al. T cell involvement in cutaneous drug eruptions. Clin. Exp. Allergy 31(9), 1398-1408 (2001). (Pubitemid 32823877)
25. Zanni MP, von Greyerz S, Schnyder B et al. T cell reactions in patients showing adverse immune reactions to drugs. Inflamm. Res. 45(Suppl 2), S79-S84 (1996). (Pubitemid 27023099)
26. Pichler WJ, Schnyder B, Zanni MP, Hari Y, von Greyerz S. Role of T cells in drug allergies. Allergy 53(3), 225-232 (1998). (Pubitemid 28125925)
27. Brander C, Mauri-Hellweg D, Bettens F et al. Heterogeneous T cell responses to β-lactam-modified self-structures are observed in penicillin-allergic individuals. J. Immunol. 155(5), 2670-2678 (1995).
28. Nyfeler B, Pichler WJ. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin. Exp. Allergy 27(2), 175-181 (1997). (Pubitemid 27085418)
29. Luque I, Leyva L, Jose Torres M et al. In vitro T-cell responses to β-lactam drugs in immediate and nonimmediate allergic reactions. Allergy 56(7), 611-618 (2001). (Pubitemid 32575434)
30. Janeway CA, Travers P, Walport M, Shlochik M. Immunobiology (5th Edition). Janeway CA, Travers P, Walport M, Shlomchik (Eds). Garland, NY, USA (2001).
31. Pichler WJ. Immune mechanism of drug hypersensitivity. Immunol. Allergy Clin. N. Am. 24(3), 373-397 (2004). (Pubitemid 38887344)
32. Padovan E, Bauer T, Tongio MM, Kalbacher H, Weltzien HU. Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy. Eur. J. Immunol. 27(6), 1303-1307 (1997). (Pubitemid 27254817)
33. + T cells. J. Invest. Dermatol. 111(4), 621-628 (1998). (Pubitemid 28452323)
34. ++ reactive human T cell clone. J. Exp. Med. 197(5), 567-574 (2003). (Pubitemid 36314652)
35. Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr. Opin. Immunol. 13(1), 114-119(2001). (Pubitemid 32096970)
36. Park BK, Pirmohamed M, Kitteringham NR. Role of drug disposition in drug hypersensitivity: a chemical, molecular, and clinical perspective. Chem. Res. Toxicol 11, 969-987 (1998).
37. Griem P, Wulferink M, Sachs B, Gonzalez JB, Gleichmann E. Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol. Today 19(3), 133-141 (1998). (Pubitemid 28194660)
38. Pichler WJ, Beeler A, Keller M et al. Pharmacological interaction of drugs with immune receptors: the p-i concept. Allergology Int. 55(1), 17-25 (2006).
39. Gerber BO, Pichler WJ. Noncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactions. Aaps J. 8(1), E160-E165 (2006).
40. Kalish RS, LaPorte A, Wood JA, Johnson KL. Sulfonamide-reactive lymphocytes detected at very low frequency in the peripheral blood of patients with drug-induced eruptions. J. Allergy Clin. Immunol. 94, 465-472 (1994).
41. van Oers MH, Pinkster J, Zeijlemaker WP. Quantification of antigen-reactive cells among human T lymphocytes. Eur. J. Immunol. 8(7), 477-484 (1978). (Pubitemid 8399177)
42. Adams PW, Opremcak EM, Orosz CG. Limiting dilution analysis of human, tetanus-reactive helper T lymphocytes. A rapid method for the enumeration of helper T lymphocytes with specificity for soluble antigens. J. Immunol. Methods 142(1), 231-241 (1991).
43. Beeler A, Engler O, Gerber BO, Pichler WJ. Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions. J. Allergy Clin. Immunol. 117(2), 455-462 (2006). (Pubitemid 43190160)
44. + T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J. Immunol. 155(1), 462-472 (1995).
45. Song A, Nikolcheva T, Krensky AM. Transcriptional regulation of RANTES expression in T lymphocytes. Immunol. Rev. 177, 236-245 (2000).
46. Ullman KS, Northrop JP, Verweij CL, Crabtree GR. Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. Annu. Rev. Immunol. 8, 421-452 (1990). (Pubitemid 20135634)
47. Ortiz BD, Nelson PJ, Krensky AM. Switching gears during T-cell maturation: RANTES and late transcription. Immunol. Today 18(10), 468-471 (1997). (Pubitemid 27441588)
48. Hashizume H, Takigawa M, Tokura Y. Characterization of drug-specific T cells in phenobarbital-induced eruption. J. Immunol. 168(10), 5359-5368 (2002). (Pubitemid 34496005)
49. Del Prete GF, De Carli M, D'Elios MM et al. Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur. J. Immunol. 23(7), 1445-1449 (1993). (Pubitemid 23218047)
50. Romagnani S. Induction of TH1 and TH2 responses: a key role for the 'natural' immune response? Immunol Today 13(10), 379-381 (1992).
51. Posadas SJ, Leyva L, Torres MJ et al. Subjects with allergic reactions to drugs show in vivo polarized patterns of cytokine expression depending on the chronology of the clinical reaction. J. Allergy Clin. Immunol. 106(4), 769-776 (2000).
52. Naisbitt DJ, Britschgi M, Wong G et al. Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Mol. Pharmacol 63(3), 732-741 (2003). (Pubitemid 36297347)
53. Naisbitt DJ, Gordon SF, Pirmohamed M et al. Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo. Br. J. Pharmacol. 133(2), 295-305. (2001). (Pubitemid 32507049)
54. Britschgi M, Pichler WJ. Acute generalized exanthematous pustulosis, a clue to neutrophil-mediated inflammatory processes orchestrated by T cells. Curr. Opin. Allergy Clin. Immunol. 2(4), 325-331. (2002). (Pubitemid 36869641)
55. Britschgi M, Steiner VC, Schmid S et al. T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J. Clin. Invest. 107(11), 1433-1441 (2001). (Pubitemid 32522037)
56. Schnyder B, Frutig K, Mauri-Hellweg D et al. T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction. Clin. Exp. Allergy 28(11), 1412-1417 (1998). (Pubitemid 28559017)
57. Yawalkar N, Egli F, Hari Y et al. Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions. Clin. Exp. Allergy 30(6), 847-855 (2000). (Pubitemid 30341287)
58. Hari Y, Urwyler A, Hurni M et al. Distinct serum cytokine levels in drug- and measles-induced exanthema. Int. Arch. Allergy Immunol. 120(3), 225-229 (1999).
59. Sachs B, Erdmann S, Al-Masaoudi T, Merk HF. In vitro drug allergy detection system incorporating human liver microsomes in chlorazepate-induced skin rash: drug-specific proliferation associated with interleukin-5 secretion. Br. J. Dermatol 144(2), 316-320(2001). (Pubitemid 32178812)
60. Pichler WJ, Zanni M, von Greyerz S et al. High IL-5 production by human drug-specific T cell clones. Int. Arch. Allergy Immunol 113(1-3), 177-180(1997). (Pubitemid 27160751)
61. Brugnolo F, Annunziato F, Sampognaro S et al. Highly Th2-skewed cytokine profile of β-lactam-specific T cells from nonatopic subjects with adverse drug reactions. J. Immunol. 163(2), 1053-1059(1999). (Pubitemid 29328119)
62. Zanni MP, Mauri-Hellweg D, Brander C et al. Characterization of lidocaine-specific T cells. J. Immunol. 158(3), 1139-1148 (1997). (Pubitemid 127469935)
63. Choquet-Kastylevsky G, Intrator L, Chenal C et al. Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome. Br. J. Dermatol. 139(6), 1026-1032 (1998). (Pubitemid 29010540)
64. Merk HF. Diagnosis of drug hypersensitivity: lymphocyte transformation test and cytokines. Toxicology 209(2), 217-220 (2005). (Pubitemid 40568654)
65. + T-cell clones from the peripheral blood of patients with cutaneous reactions to β-lactam antibiotics, Br. J. Dermatol. 128(6), 619-626(1993). (Pubitemid 23172018)
66. Sieben S, Kawakubo Y, Al Masaoudi T, Merk HF, Blomeke B. Delayed-type hypersensitivity reaction to paraphenylenediamine is mediated by 2 different pathways of antigen recognition by specific aβ human T-cell clones. J. Allergy Clin. Immunol. 109(6), 1005-1011 (2002). (Pubitemid 34634313)
67. Schmid DA, Depta JP, Pichler WJ. T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity. Clin. Exp. Allergy 36(1), 59-69 (2006).
68. Everness KM, Gawkrodger DJ, Botham PA, Hunter JA. The discrimination between nickel-sensitive and non-nickel-sensitive subjects by an in vitro lymphocyte transformation test. Br. J. Dermatol. 122(3), 293-298 (1990). (Pubitemid 20122714)
69. Warrington RJ, Tse KS. Lymphocyte transformation studies in drug hypersensitivity. Can. Med. Assoc. J 120, 1089-1094 (1979). (Pubitemid 9172887)
70. Barna BP, Gogate P, Deodhar SD, Moeder M. Lymphocyte transformation and radioallergosorbent tests in drug hypersensitivity. Am. J. Clin. Pathol. 73(2), 172-176 (1980). (Pubitemid 10106782)
71. Berg PA, Brattig N, Diao, G-J, Schuff-Werner P. Diagnose arzneimittelbedingter Nebenwirkungen mit Hilfe des Lyphozytentransformationstests. Allergologie 6, 77-81 (1983). (Pubitemid 13125389)
72. Schnyder B, Pichler WJ. Skin and laboratory tests in amoxicillin- and penicillin-induced morbilliform skin eruption. Clin. Exp. Allergy 30(4), 590-595 (2000). (Pubitemid 30253200)
73. Jiang X, Khursigara G, Rubin RL. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science 266(5186), 810-813 (1994). (Pubitemid 24359291)
74. Cribb AE, Miller M, Tesoro A, Spielberg SR Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from humans and dogs. Mol. Pharmacol. 38(5), 744-751 (1990).
75. Goebel C, Kubicka-Muranyi M, Tonn T, Gonzalez J, Gleichmann E. Phagocytes render chemicals immunogenic: oxidation of gold(1) to the T cell-sensitizing gold(III) metabolite generated by mononuclear phagocytes. Arch. Toxicol. 69(7), 450-459 (1995).
76. Rossert J. Drug-induced acute interstitial nephritis. Kidney Int. 60(2), 804-817 (2001). (Pubitemid 32678929)
77. Lee WM. Drug-induced hepatotoxicity. N. Engl. J. Med 349(5), 474-485 (2003). (Pubitemid 36910027)
78. Stepp SE, Mathew PA, Bennett M, de Saint Basile G, Kumar V. Perforin: more than just an effector molecule. Immunol. Today 21(6), 254-256(2000). (Pubitemid 30333296)
79. Posadas SJ, Padial A, Torres MJ et al. Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity. J. Allergy Clin. Immunol. 109(1), 155-161 (2002). (Pubitemid 34112146)
80. Kuechler PC, Britschgi M, Schmid S et al. Cytotoxic mechanisms in different forms of T-cell-mediated drug allergies. Allergy 59(6), 613-622 (2004). (Pubitemid 38748060)
81. Schmid S, Kuechler PC, Britschgi M et al. Acute generalized exanthematous pustulosis: role of cytotoxic T cells in pustule formation. Am. J. Pathol. 161(6), 2079-2086 (2002). (Pubitemid 35434854)
82. + T cell subsets against keratinocytes. J. Immunol. 165(6), 3058-3064 (2000).
83. Roujeau JC, Albengres E, Moritz S. Lymphocyte transformation test in drug-induced toxic epidermal necrolysis. Int. Arch. Allergy Appl. Immunol. 78, 22-24 (1985). (Pubitemid 16255568)
84. Pirmohamed M. Genetic factors in the predisposition to drug-induced hypersensitivity reactions. Aaps J. 8(1), E20-26 (2006). (Pubitemid 44603868)
85. Spielberg SP, Gordon GB, Blake DA, Goldstein DA, Herlong HF. Predisposition to phenytoin hepatotoxicity assessed in vitro. N. Engl. J. Med 305(13), 722-727 (1981). (Pubitemid 11062054)
86. Gennis MA, Vemuri R, Burns EA et al. Familial occurrence of hypersensitivity to phenytoin. Am. J. Med. 91(6), 631-634 (1991).
87. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J. Clin. Invest. 82(6), 1826-1832 (1988). (Pubitemid 19054926)
88. *5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 359(9308), 727-732 (2002). (Pubitemid 34215071)
89. +5701 and a haplotypic Hsp70-Hom variant. Proc. Natl Acad. Sci. USA 101(12), 4180-4185 (2004). (Pubitemid 38405903)
90. Chung WH, Hung SI, Hong HS et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 428(6982), 486 (2004).
91. Hung SI, Chung WH, Jee SH et al. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet. Genom. 16(4), 297-306 (2006).
92. *580I allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc. Natl Acad. Sci. USA 102(11), 4134-4139 (2005).
93. Lonjou C, Thomas L, Borot N et al. A marker for Stevens-Johnson syndrome: ethnicity matters. Pharmacogenomics J. (2006).
94. Martin AM, Krueger R, Almeida CA et al. A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome. Pharmacogenet. Genom. 16(5), 353-357 (2006).
95. Renn CN, Straff W, Dorfmuller A et al. Amoxicilin-induced exanthema in young adults with infectious mononucleosis: demonstration of drug-specific lymphocyte reactivity. Br. J. Dermatol. 147(6), 1166-1170 (2002). (Pubitemid 36963023)
96. Pichler WJ. Predictive drug allergy testing: an alternative viewpoint. Toxicology 158(1-2), 31-41 (2001). (Pubitemid 32119494)
97. Schmid D, Campi P, Pichler W. Hypersensitivity reactions to quinolones. Curr. Pharmaceut. Des. 12(26), 3313-3326 (2006). (Pubitemid 44364120)